Drawing for BIFORTIF B.INFANTIS 35624 CLINICALLY STUDIED

USPTO serial 79148385

BIFORTIF B.INFANTIS 35624 CLINICALLY STUDIED

Reviewed by CopyMark Law Group

Reg. 4729651Status 404
Filing date
Status date
Registration date
May 5, 2015
Examiner
KING, LINDA M
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BIFORTIF B.INFANTIS 35624 CLINICALLY STUDIED?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Dmitriy O. Makarov

Dmitriy O. Makarov IpHorgan Ltd.195 Arlington Heights Rd, Suite #125Buffalo Grove, IL 60089-1768UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Dietetic food and substances adapted for medical use containing B.infantis 35624, namely, reconstituted nutritional beverages containing cereals and/or proteins, cereal bars, powdered foods containing cereal and/or proteins; medicinal drinks containing B.infantis 35624; medicinal food supplements containing B.infantis 35624; health food supplements containing B.infantis 35624; dietary supplements containing B.infantis 35624; vitamin preparations containing B.infantis 35624; dietetic nutritive substances for medical use, containing B.infantis 35624, namely, complete and incomplete nutritional beverages and powders for dietary management of a specific disease or condition; protein dietary supplements containing B.infantis 35624; vitamin and mineral supplements containing B.infantis 35624; mineral food supplements containing B.infantis 35624; dietetic yogurts adapted for medical use containing B.infantis 35624; food for babies containing B.infantis 35624; food supplements and medical food supplements, namely, bacteriological cultures, bacteria and preparations of bacteria containing B.infantis 35624SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 8, 2024DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Oct 8, 2024DETHDEATH OF INTERNATIONAL REGISTRATION—
Oct 7, 2024DETHDEATH OF INTERNATIONAL REGISTRATION—
Oct 7, 2024DETHDEATH OF INTERNATIONAL REGISTRATION—
Oct 7, 2024DETHDEATH OF INTERNATIONAL REGISTRATION—
Oct 7, 2024DETHDEATH OF INTERNATIONAL REGISTRATION—
Oct 7, 2024DETHDEATH OF INTERNATIONAL REGISTRATION—
Oct 7, 2024DETHDEATH OF INTERNATIONAL REGISTRATION—
Oct 7, 2024DETHDEATH OF INTERNATIONAL REGISTRATION—
Oct 7, 2024DETHDEATH OF INTERNATIONAL REGISTRATION—
Oct 7, 2024DETHDEATH OF INTERNATIONAL REGISTRATION—
Oct 7, 2024DETHDEATH OF INTERNATIONAL REGISTRATION—
Oct 7, 2024DETHDEATH OF INTERNATIONAL REGISTRATION—
Oct 16, 2022INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Sep 19, 2022XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Sep 19, 2022XXCRGENERIC MADRID TRANSACTION CREATED—
Jul 26, 2022INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jul 9, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 26, 2021C71TCANCELLED SECTION 71—
May 5, 2020REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Mar 6, 2020ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Sep 11, 2015FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 26, 2015FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 26, 2015FIMPFINAL DISPOSITION PROCESSED—
Aug 5, 2015FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 5, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 17, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 17, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 14, 2015GPNXNOTIFICATION PROCESSED BY IB—
Jan 28, 2015OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 28, 2015OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 28, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 15, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 14, 2015ALIEASSIGNED TO LIE—
Dec 23, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 2, 2014TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 1, 2014CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 1, 2014TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 24, 2014RFNTREFUSAL PROCESSED BY IB—
Jul 8, 2014RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 8, 2014RFRRREFUSAL PROCESSED BY MPU—
Jul 8, 2014RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 7, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 4, 2014MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 30, 2014DOCKASSIGNED TO EXAMINER—
Jun 30, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 26, 2014REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance